# US 2020/0223839 A1 · Fluoro-containing compounds, use and preparation thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0223839 A1
- Document ID: US20200223839A1
- Status: Published application
- Kind: A1
- Application number: 16/629,557
- Filed: 2018-06-27
- Published: 2020-07-16
- Earliest claimed: 2017-07-09
- Assignees: Jiangsu Yingkebeita Yiyaokeji Co. Ltd
- Applicants: Jiangsu Yingkebeita Yiyaokeji Co. Ltd
- Inventors: Yao MA
- Web page: https://patentgrep.com/patent/US20200223839A1

## CPC

- C07D 417/12: linked by a chain containing hetero atoms as chain links
- A61K 31/498: Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
- A61P 35/00: Antineoplastic agents
- C07D 241/22: Benzenesulfonamido pyrazines
- C07D 241/44: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D 277/52: to sulfur atoms, e.g. sulfonamides
- C07D 285/06: 1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present teachings relate to a fluoro-containing compound, a composition thereof, a method of using the compound or the composition in treating a disease, and a method of preparing the compound. In a particular example, the compound is chosen from Formulae 4, 4f, 7, 8, 9, 10, 11, or 12, or a salt thereof, or a solvate of any of the foregoing.

## Claims

### Claim 1 (depends on 37)

The compound of claim 37, wherein
the compound has Formula VIII:
a salt thereof, or a solvate of any of the foregoing;
wherein
R2 at each occurrence independently is chosen from halogen, azide, alkyl, aralkyl, alkenyl, alkynyl, cycloalkyl, hydroxyl, alkoxy, amino (or quaternized amino), nitro, sulfhydryl, imino, amido, phosphonate, phosphinate, carbonyl, carboxyl, silyl, ether, alkylthio, sulfonyl, sulfonamido, ketone, aldehyde, ester, heterocyclyl, aromatic or heteroaromatic moieties, —CF3, or —CN;
R3 at each occurrence independently is chosen from halogen, azide, alkyl, aralkyl, alkenyl, alkynyl, cycloalkyl, hydroxyl, alkoxy, amino (or quaternized amino), nitro, sulfhydryl, imino, amido, phosphonate, phosphinate, carbonyl, carboxyl, silyl, ether, alkylthio, sulfonyl, sulfonamido, ketone, aldehyde, ester, heterocyclyl, aromatic or heteroaromatic moieties, —CF3, or —CN;
m is 0, 1, 2, 3, or 4; and
n′ is 0, 1, 2, 3, or 4.

### Claim 2 (depends on 1)

The compound of claim 1, wherein the compound has Formula IX:
a salt thereof, or a solvate of any of the foregoing;
wherein
R2 is chosen from halogen, azide, alkyl, aralkyl, alkenyl, alkynyl, cycloalkyl, hydroxyl, alkoxy, amino (or quaternized amino), nitro, sulfhydryl, imino, amido, phosphonate, phosphinate, carbonyl, carboxyl, silyl, ether, alkylthio, sulfonyl, sulfonamide, ketone, aldehyde, ester, heterocyclyl, aromatic or heteroaromatic moieties, —CF3, or —CN;
R3 at each occurrence independently is chosen from halogen, azide, alkyl, aralkyl, alkenyl, alkynyl, cycloalkyl, hydroxyl, alkoxy, amino (or quaternized amino), nitro, sulfhydryl, imino, amido, phosphonate, phosphinate, carbonyl, carboxyl, silyl, ether, alkylthio, sulfonyl, sulfonamide, ketone, aldehyde, ester, heterocyclyl, aromatic or heteroaromatic moieties, —CF3, or —CN; and
m is 0, 1, 2, 3, or 4.

### Claim 3 (depends on 1)

The compound of claim 1, wherein m is 0.

### Claim 4 (depends on 1)

The compound of claim 1, wherein R2 is chosen from halogen, alkyl, alkoxy, amino, carbonyl, —CF3, or —CN.

### Claim 5 (depends on 4)

The compound of claim 4, wherein R2 is chosen from methyl, ethyl, propyl, or isopropyl, each optionally substituted with one or more substituents, each independently chosen from F, Cl, Br, hydroxyl, alkoxy, amino, —CF3, or —CN.

### Claim 6 (depends on 4)

The compound of claim 4, wherein R2 is alkoxy, halogen, amino, or carbonyl.

### Claim at position 7

7-26. (canceled)

### Claim 27

A compound chosen from:
a salt thereof, or a solvate of any of the foregoing.

### Claim 28 (depends on 27)

The compound of claim 27, wherein the compound comprises Formula 4f:
a salt thereof, or a solvate of any of the foregoing.

### Claim 29 (depends on 27)

The compound of claim 27, wherein the compound comprises 7:
a salt thereof, or a solvate of any of the foregoing.

### Claim 30 (depends on 37)

A composition comprising the compound of claim 37.

### Claim 31 (depends on 30)

The composition of claim 30, wherein the composition is a pharmaceutical composition.

### Claim 32 (depends on 37)

A method of treating a disease in a subject comprising administering to a subject in need thereof a therapeutically effective amount of at least one compound of claim 37.

### Claim 33

A method of treating a disease in a subject comprising administering to a subject in need thereof a therapeutically effective amount of at least one compound chosen from:
a salt thereof, or a solvate of any of the foregoing.

### Claim 34 (depends on 33)

The method of claim 33, wherein the disease is cancer.

### Claim 35 (depends on 30)

A method of treating a disease in a subject comprising administering to a subject in need thereof a therapeutically effective amount of at least one composition of claim 30.

### Claim 36

(canceled)

### Claim 37

A compound of Formula IV:
a salt thereof, or a solvate of any of the foregoing;
wherein
R1 is an aryl group;
R2 at each occurrence independently is chosen from halogen, azide, alkyl, aralkyl, alkenyl, alkynyl, cycloalkyl, hydroxyl, alkoxy, amino (or quaternized amino), nitro, sulfhydryl, imino, amido, phosphonate, phosphinate, carbonyl, carboxyl, silyl, ether, alkylthio, sulfonyl, sulfonamido, ketone, aldehyde, ester, heterocyclyl, aromatic or heteroaromatic moieties, —CF3, or —CN; and
n′ is 0, 1, 2, 3, or 4.

### Claim 38 (depends on 37)

The compound of claim 37, wherein n′ is 0, 1, or 2.

### Claim 39 (depends on 37)

The compound of claim 37, wherein the compound has Formula V:
